Miguel Martin Selected Research

Miguel Martin Research Topics

Disease

108	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2002
46	Neoplasms (Cancer) 07/2022 - 01/2002
10	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2012
9	Neutropenia 10/2021 - 08/2009
8	Triple Negative Breast Neoplasms 01/2022 - 01/2016
8	Fatigue 01/2021 - 04/2011
7	Disease Progression 06/2021 - 08/2007
7	Febrile Neutropenia 01/2020 - 02/2008
6	Diarrhea 08/2021 - 01/2010
4	Anemia 02/2020 - 05/2013
4	Exanthema (Rash) 05/2015 - 01/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 04/2011
3	Pain (Aches) 12/2020 - 09/2012
3	Nausea 02/2020 - 03/2016
3	Pathologic Complete Response 01/2020 - 11/2010
3	Leukopenia 01/2019 - 08/2009
3	Melanoma (Melanoma, Malignant) 11/2016 - 10/2014
2	Thrombocytopenia (Thrombopenia) 01/2022 - 05/2013
2	Vomiting 12/2017 - 03/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 10/2014
2	Hypertension (High Blood Pressure) 01/2015 - 04/2011
2	Cardiotoxicity 12/2012 - 10/2011
2	Heart Failure 10/2011 - 12/2004

Drug/Important Bio-Agent (IBA)

30	Hormones (Hormone)IBA 08/2022 - 04/2011
24	Trastuzumab (Herceptin)FDA Link 12/2021 - 01/2010
23	ErbB Receptors (EGF Receptor)IBA 08/2022 - 11/2009
22	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2003
14	taxaneIBA 10/2021 - 01/2002
13	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2002
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2003
12	Estrogen ReceptorsIBA 10/2021 - 06/2008
12	AnthracyclinesIBA 01/2021 - 01/2002
11	abemaciclibIBA 08/2022 - 01/2016
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 01/2002
10	Taxoids (Taxanes)IBA 01/2021 - 07/2006
9	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2011
9	Pharmaceutical PreparationsIBA 11/2018 - 01/2006
8	palbociclibIBA 01/2022 - 01/2016
8	human ERBB2 proteinIBA 12/2021 - 11/2014
8	neratinibIBA 12/2021 - 12/2013
7	Tyrosine Kinase InhibitorsIBA 12/2021 - 11/2009
7	pertuzumabIBA 11/2019 - 01/2016
7	Lapatinib (GW572016)FDA Link 03/2016 - 01/2013
7	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 06/2005
6	Progesterone Receptors (Progesterone Receptor)IBA 06/2021 - 03/2009
6	Vinorelbine (Navelbine)FDA LinkGeneric 02/2020 - 01/2002
6	Ado-Trastuzumab EmtansineIBA 11/2019 - 01/2017
5	ribociclibIBA 01/2022 - 10/2017
5	Letrozole (Femara)FDA LinkGeneric 01/2022 - 11/2016
5	Fulvestrant (Faslodex)FDA Link 12/2020 - 10/2010
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2010
5	Phenobarbital (Luminal)FDA Link 01/2019 - 03/2009
4	Cyclin-Dependent Kinase 4IBA 01/2022 - 01/2020
4	Gemcitabine FDA Link 02/2020 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2010
4	Pemetrexed (MTA)FDA Link 05/2013 - 01/2006
4	Bevacizumab (Avastin)FDA Link 01/2013 - 01/2011
3	talazoparibIBA 01/2022 - 01/2018
3	Aromatase InhibitorsIBA 06/2021 - 01/2019
3	eribulin FDA Link 02/2020 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 05/2008
3	Tumor Biomarkers (Tumor Markers)IBA 11/2019 - 01/2019
3	Cytotoxins (Cytolysins)IBA 01/2018 - 07/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2011 - 01/2002
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2009 - 02/2008
2	Tamoxifen FDA LinkGeneric 08/2022 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 07/2022 - 08/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2016
2	Alanine Transaminase (SGPT)IBA 10/2021 - 01/2018
2	Epidermal Growth Factor (EGF)IBA 10/2021 - 12/2013
2	Poly Adenosine Diphosphate RiboseIBA 02/2020 - 01/2018
2	Biological ProductsIBA 01/2020 - 03/2009
2	Denosumab FDA Link 01/2020 - 09/2012
2	Monoclonal AntibodiesIBA 01/2020 - 01/2011
2	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2016
2	RNA (Ribonucleic Acid)IBA 11/2019 - 04/2014
2	Formaldehyde (Formol)FDA Link 11/2019 - 08/2016
2	ParaffinIBA 11/2019 - 08/2016
2	Estrogens (Estrogen)FDA Link 01/2019 - 08/2010
2	PlatinumIBA 01/2017 - 01/2016
2	VaccinesIBA 01/2016 - 01/2011
2	IgA receptor (protein B)IBA 03/2015 - 10/2014
2	Glycoproteins (Glycoprotein)IBA 03/2015 - 10/2014
2	RamucirumabIBA 01/2015 - 11/2009
2	ProdrugsIBA 01/2015 - 04/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 01/2011
2	TubulinIBA 08/2010 - 08/2007
2	Sunitinib (Sutent)FDA Link 05/2010 - 01/2010
2	VitaminsIBA 08/2009 - 01/2006
2	Thymidine PhosphorylaseIBA 06/2007 - 01/2002
1	Diphosphonates (Bisphosphonates)IBA 03/2022

Therapy/Procedure

57	Therapeutics 08/2022 - 12/2004
31	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
11	Adjuvant Chemotherapy 01/2022 - 06/2005
9	Neoadjuvant Therapy 01/2022 - 04/2011
2	Drug Tapering 01/2021 - 01/2010
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2013
2	Immunotherapy 11/2019 - 11/2016
1	Complementary Therapies (Alternative Medicine) 07/2022